These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15852591)

  • 1. When genes and drugs collide.
    Kiser K
    Minn Med; 2005 Mar; 88(3):22-4, 54. PubMed ID: 15852591
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of drug transporter for the internal medicine clinic].
    Siegmund W; Cascorbi I; Weitschies W; Kroemer HK
    Internist (Berl); 2003 Feb; 44(2):219-26. PubMed ID: 12674742
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
    Mourad M; Wallemacq P; De Meyer M; Malaise J; De Pauw L; Eddour DC; Goffin E; Lerut J; Haufroid V
    Transplantation; 2008 Apr; 85(7 Suppl):S19-24. PubMed ID: 18401258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnicity and pharmacogenetics.
    Smith MW; Mendoza RP
    Mt Sinai J Med; 1996; 63(5-6):285-90. PubMed ID: 8898529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A question-based approach to adopting pharmacogenetics to understand risk for clinical variability in pharmacokinetics in early drug development.
    Evers R; Blanchard RL; Warner AW; Cutler D; Agrawal NG; Shaw PM
    Clin Pharmacol Ther; 2014 Sep; 96(3):291-5. PubMed ID: 25141952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ethnic background related pharmacological differences].
    Reinbold H
    MMW Fortschr Med; 2007 Oct; 149(42):34, 36. PubMed ID: 17987717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
    Sikka R; Magauran B; Ulrich A; Shannon M
    Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics: using DNA to optimize drug therapy.
    Lanfear DE; McLeod HL
    Am Fam Physician; 2007 Oct; 76(8):1179-82. PubMed ID: 17990842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics, race, and psychiatry: prospects and challenges.
    Jones DS; Perlis RH
    Harv Rev Psychiatry; 2006; 14(2):92-108. PubMed ID: 16603475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of osteoporosis: future perspectives.
    Marini F; Brandi ML
    Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confounding in genetic association studies and its solutions.
    Hu D; Ziv E
    Methods Mol Biol; 2008; 448():31-9. PubMed ID: 18370229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach?
    Tomlinson B; Hu M; Lee VW
    Mol Nutr Food Res; 2008 Jul; 52(7):799-809. PubMed ID: 18618477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current overview of pharmacogenetics.
    McLeod HL
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):205-7. PubMed ID: 16163181
    [No Abstract]   [Full Text] [Related]  

  • 16. [Goals of pharmacogenetics for predetermined therapy. With genetic record to the doctor].
    Eiden P
    MMW Fortschr Med; 2000 Aug; 142(31-32):4-6. PubMed ID: 10992758
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
    Murray M
    J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of pharmacogenetics in the treatment of epilepsy.
    Depondt C
    Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation.
    Ito S
    Clin Pharmacol Ther; 2014 Sep; 96(3):281-3. PubMed ID: 25141949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ancillary risk information and pharmacogenetic tests: social and policy implications.
    Henrikson NB; Burke W; Veenstra DL
    Pharmacogenomics J; 2008 Apr; 8(2):85-9. PubMed ID: 17486108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.